Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)
Public ClinicalTrials.gov record NCT00163501. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial to Assess the Long Term Safety of Ciclesonide, Applied as a Nasal Spray (200 Mcg, Once Daily) in the Treatment of Perennial Allergic Rhinitis (PAR) in Patients 12 Years and Older
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of perennial allergic rhinitis.
Study identification
- NCT ID
- NCT00163501
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 600 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2003 (Type not available)
- Primary completion
- Apr 2005 (Actual)
- Completion
- Apr 2005 (Actual)
- Last update posted
- Nov 30, 2016
2003 – 2005
United States locations
- U.S. sites
- 41
- U.S. states
- 21
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altana Pharma/Nycomed | Encinitas | California | 92024 | — |
| Altana Pharma/Nycomed | Huntington Beach | California | 92647 | — |
| Altana Pharma/Nycomed | Long Beach | California | 90806 | — |
| Altana Pharma/Nycomed | Los Angeles | California | 90025 | — |
| Altana Pharma/Nycomed | Mission Viejo | California | 92691 | — |
| Altana Pharma/Nycomed | Newport Beach | California | 92660 | — |
| Altana Pharma/Nycomed | San Diego | California | 92103 | — |
| Altana Pharma/Nycomed | San Diego | California | 92120 | — |
| Altana Pharma/Nycomed | Stockton | California | 95207 | — |
| Altana Pharma/Nycomed | Vista | California | 92083 | — |
| Altana Pharma/Nycomed | Trumbull | Connecticut | 06611 | — |
| Altana Pharma/Nycomed | Clearwater | Florida | 33761 | — |
| Altana Pharma/Nycomed | DeLand | Florida | 32720 | — |
| Altana Pharma/Nycomed | Atlanta | Georgia | 30342 | — |
| Altana Pharma/Nycomed | Normal | Illinois | 61761 | — |
| Altana Pharma/Nycomed | Overland Park | Kansas | 66210 | — |
| Altana Pharma/Nycomed | New Orleans | Louisiana | 70112 | — |
| Altana Pharma/Nycomed | Bethesda | Maryland | 20814 | — |
| Altana Pharma/Nycomed | North Dartmouth | Massachusetts | 02747 | — |
| Altana Pharma/Nycomed | Forked River | New Jersey | 08731 | — |
| Altana Pharma/Nycomed | Skillman | New Jersey | 08558 | — |
| Altana Pharma/Nycomed | Springfield | New Jersey | 07081 | — |
| Altana Pharma/Nycomed | Liverpool | New York | 13088 | — |
| Altana Pharma/Nycomed | Raleigh | North Carolina | 27607 | — |
| Altana Pharma/Nycomed | Winston-Salem | North Carolina | 27103 | — |
| Altana Pharma/Nycomed | Cincinnati | Ohio | 45219 | — |
| Altana Pharma/Nycomed | Cincinnati | Ohio | 45246 | — |
| Altana Pharma/Nycomed | Oklahoma City | Oklahoma | 73104 | — |
| Altana Pharma/Nycomed | Portland | Oregon | 97213 | — |
| Altana Pharma/Nycomed | Easton | Pennsylvania | 18045 | — |
| Altana Pharma/Nycomed | Pittsburgh | Pennsylvania | 15241 | — |
| Altana Pharma/Nycomed | Cranston | Rhode Island | 02920 | — |
| Altana Pharma/Nycomed | Austin | Texas | 78731 | — |
| Altana Pharma/Nycomed | Dallas | Texas | 75231 | — |
| Altana Pharma/Nycomed | Houston | Texas | 77054 | — |
| Altana Pharma/Nycomed | Kerrville | Texas | 78028 | — |
| Altana Pharma/Nycomed | New Braunfels | Texas | 78130 | — |
| Altana Pharma/Nycomed | San Antonio | Texas | 78229 | — |
| Altana Pharma/Nycomed | Salt Lake City | Utah | 84111 | — |
| Altana Pharma/Nycomed | Richmond | Virginia | 23226 | — |
| Altana Pharma/Nycomed | Milwaukee | Wisconsin | 53201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00163501, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 30, 2016 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00163501 live on ClinicalTrials.gov.